Azzad Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Azzad Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-18,326	Closed	-$961K	–	295
2014 Q2	$961K	Sell	18,326 -12,258	-40%	-$627K	0.58%	42
2014 Q1	$1.62M	Buy	30,584 +1,664	+6%	+$76.9K	1.07%	4
2013 Q4	$1.16M	Buy	28,920 +1,240	+4%	+$48.8K	0.84%	13
2013 Q3	$1.05M	Hold	27,680	–	–	0.86%	10
2013 Q2	$1.05M	Buy	+27,680	New	+$1.08M	0.9%	10

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Azzad Asset Management's TEVA Position: Q3 2014 in Review

Azzad Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2014, closing a stake of 18,326 shares — an estimated $961K sold.

Azzad Asset Management first reported a position in TEVA in Q2 2013 and held it in 5 quarters. The position peaked at $1.62M in Q1 2014. 772 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

Azzad Asset Management reported no remaining Teva Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
Azzad Asset Management sold 18,326 Teva Pharmaceuticals shares in Q3 2014, an estimated $961K.
Azzad Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 5 quarters.
Azzad Asset Management's Teva Pharmaceuticals position peaked at $1.62M in Q1 2014.
772 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2014.

Based on Azzad Asset Management's 13F filing for Q3 2014, filed 3 Apr 2024.